In the present study, we demonstrated that P7, a novel SLAMF1-derived peptide, dampens pro-inflammatory signaling, likely through an inhibitory effect on TLR4-mediated signaling, and has protective properties against experimentally induced MI. The gene discussed is TLR4; the disease is myocardial infarction.